Otros idiomas Bausch Health Companies Inc. Toronto S.E.

Acciones

BHC

CA0717341071

Farmacéuticos

Mercado cerrado - Toronto S.E. Otros sitios de cotización 22:00:00 17/01/2025			Varia. Cinco días.	Varia. 1 de enero.
10,76 ^CAD	-2,27 %		-5,45 %	-7,40 %

17/01	RBC sobre la tercera aprobación provisional de la FDA para la rifaximina 550 mg a Amneal Pharmaceuticals	MT
17/01	Xifaxan de Bausch Health seleccionado para las negociaciones de precios de medicamentos de Medicare	MT

Otros idiomas

RBC on FDA's Third Tentative Approval For Rifaximin 550mg to Amneal Pharmaceuticals	17/01
Bausch Health's Xifaxan Selected for Medicare Drug Price Negotiations	17/01
Bausch Health Notes Xifaxan 550 mg Selected For Medicare 2nd Round Negotiations	17/01
Bausch + Lomb Acquires Whitecap Biosciences, Financial Details Not Disclosed	13/01
Bausch + Lomb Brief: Says "Bolsters Pipeline" with Acquisition of Whitecap Biosciences	13/01
Bausch + Lomb Brief: Launching Lenses in the European Union	13/01
Contact lens maker Bausch + Lomb says it is exploring sale	12/12
Bausch + Lomb exploring several options including a potential sale	12/12
Bausch Health Says Bausch + Lomb Subsidiary Sale Under Consideration	12/12
Bausch + Lomb Brief: Does not intend to provide additional detail until further disclosure is "Appropriate or Necessary"	12/12
Bausch + Lomb Brief: Adds "That process is ongoing, and there can be no assurance that it will result in a transaction"	12/12
Bausch + Lomb Brief: Says a potential sale is one of several options being explored to complete a full separation from Bausch Health	12/12
Bausch + Lomb Brief: Comes After Financial Times reported that Blackstone may drop out of consortium bidding on It	12/12
Bausch + Lomb Brief: Responding to Rumors of a Potential Sale	12/12
TSX Closer: The Market Surges as the Bank of Canada Makes Its Jumbo Cut, Further Cuts Predicted	11/12
TSX up 105 Points at Midday, With Info Tech, Energy, Higher; Healthcare The Biggest Decliner	11/12
Toronto Stocks Rise, BOC Cuts Rate by 50 Basis Points; Bausch Health Shares Down as Potential Buyer Balks	11/12
Bausch+Lomb Down 10% in US Premarket After Acquiring Elios Vision for Undisclosed Sum	11/12
Bausch + Lomb Brief: Acquiring Elios Vision, "Significantly Enhances" Glaucoma Treatment Capabilities	11/12
Bausch Health Appoints New Chief Medical Officer and Head of R&D	03/12
Toronto Stocks Pull Back; Lightspeed Commerce Shares Fall on Layoff Plans	02/12
Bausch Health Companies Inc. Appoints Jonathan Sadeh M.D., M.Sc as Executive Vice President, Chief Medical Officer and Head of R&D	02/12
US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug	18/11
Bausch Health Canada Receives Reimbursement Recommendation for Acne Treatment	18/11
Bausch Acne Gel Gets Reimbursement Nods from Canada's Drug Agency and Quebec's INESSS	18/11

Conviértase en miembro para acceder a más noticias.

Inscripción 100% Gratuita

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Bausch Health Companies Inc. Toronto S.E.

Acciones

BHC

CA0717341071

Farmacéuticos

Otros idiomas

Filtros